EUVIMEDEUVIMED entdecken
Open Access

GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice

Yang Ge iD, Tian Tian iD, Bolong Li iD, Peter Axerio-Cillies, Wenlin Chen, Xin Qin, Mudi Zhao, Qi-Cheng Sun iD, Jiaqi Li, Stan B Floresco, Lidong Liu iD, Xin Yang iD und 1 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.ady3891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Yang Ge und 12 weiteren Autor:innen. Beteiligte Einrichtung: Djavad Mowafaghian Centre for Brain Health and Department of Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada. Hauptthemen laut MEDLINE: Receptors, N-Methyl-D-Aspartate, Methyl-CpG-Binding Protein 2, Behavior, Animal, Nerve Tissue Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Canadian institute of Health Research, Shenzhen Science and Technology Program, NSFC-Guangdong Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The GluN2B subunit of N -methyl- d -aspartate receptors (NMDARs) plays a central role in synaptic development and plasticity, and its hypofunction is linked to autism spectrum disorder (ASD), severe neurodevelopmental delay, and other neuropsychiatric diseases. Therefore, enhancing the function of this NMDAR subunit may provide an effective therapeutic strategy for correcting synaptic and behavioral deficits associated with GluN2B hypofunction. Here, we developed a class of GluN2B-selective positive allosteric modulators and characterized the pharmacological properties and binding site of the lead compound, 175. Systemic application of 175 facilitates hippocampal long-term depression in rats. 175 restores performances in open-field exploration and three-chamber test in Mecp2 overexpression mice that exhibit GluN2B hypofunction and autism-like features. Treatment with 175 also reverses behavioral abnormalities in open-field, Y-maze spontaneous alternation, three-chamber test, and prepulse inhibition in Disc1 mutant mice. Our findings introduce a pharmacological tool for selectively potentiating GluN2B-NMDAR function and highlight its therapeutic potential for cognitive and behavioral symptoms associated with GluN2B hypofunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, N-Methyl-D-AspartateMethyl-CpG-Binding Protein 2Behavior, AnimalNerve Tissue ProteinsCognitionAnimalsMice, TransgenicMiceAllosteric RegulationMaleHippocampusRatsDisease Models, Animal

Substanzen

Receptors, N-Methyl-D-AspartateMethyl-CpG-Binding Protein 2NR2B NMDA receptorNerve Tissue ProteinsDisc1 protein, mouse

Autor:innen und Institutionen

  • Djavad Mowafaghian Centre for Brain Health and Department of Medicine, University of British Columbia, Vancouver, BC V6T 2B5, Canada.
  • Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology, Shenzhen, PR China.
  • Shenzhen Key Laboratory of Translational Research for Brain Diseases, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, PR China.
  • Fudan-SANS Neuroscience Center, Fudan University, Shanghai, PR China.
  • School of Finance, Southwestern University of Finance and Economics, Chengdu, PR China.

ORCID-Profile: Yang Ge, Tian Tian, Bolong Li, Qi-Cheng Sun, Lidong Liu, Xin Yang, Yu Tian Wang

Förderung

  • Canadian institute of Health Research
  • Shenzhen Science and Technology Program
  • NSFC-Guangdong Joint Fund
  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Medical Research Fund
  • Research Fund for International Scientists of National Natural Science Foundation of China
  • HSFBC&Y Chair in Stroke Research

Zitieren

APA

Ge, Y., Tian, T., Li, B., Axerio-Cillies, P., Chen, W., Qin, X., Zhao, M., Sun, Q. C., Li, J., Floresco, S. B., Liu, L., Yang, X., & Wang, Y. T. (2026). GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice. Science Advances. https://doi.org/10.1126/sciadv.ady3891

Vancouver

Ge Y, Tian T, Li B, Axerio-Cillies P, Chen W, Qin X, et al. GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice. Science Advances. 2026. doi:10.1126/sciadv.ady3891

BibTeX
@article{Ge2026,
  author = {Ge, Yang and Tian, Tian and Li, Bolong and Axerio-Cillies, Peter and Chen, Wenlin and Qin, Xin and Zhao, Mudi and Sun, Qi-Cheng and Li, Jiaqi and Floresco, Stan B and Liu, Lidong and Yang, Xin and Wang, Yu Tian},
  title = {GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and behavioral abnormalities in Mecp2 and Disc1 transgenic mice},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.ady3891}
}
Kostenlos starten →